EDUSELL
Financial Market Examiner
Midas Crypto Vault
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews
No Result
View All Result
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews
No Result
View All Result
Financial Market Examiner
No Result
View All Result
Home Crypto News

Cancer Drug Company Accuses US Market Makers Of Stock Spoofing

Admin by Admin
December 2, 2022
in Crypto News
0
Cancer Drug Company Accuses US Market Makers Of Stock Spoofing
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter
Event Event

A cancer-focused biotechnology company has sued eight of the US’s largest market-making traders including Citadel Securities, Susquehanna and Virtual, alleging that they deliberately drove down its share price by placing sell orders they had no intention of executing.

The complaint, filed by Northwest Biotherapeutics in a federal court in New York on Thursday, claimed that the traders deliberately engaged in repeated spoofing that interfered with the natural forces of supply and demand” by placing tens of millions of fake orders between December 2017 and August of this year.

The trading companies would then cancel those orders and buy Northwest’s shares at an artificially lower price.

Lawyers for the clinical-stage biotechnology firm claimed a “particularly egregious example” of this activity took place in May, after the publication of what they maintain were positive trial data for Northwest’s DCVax-L brain cancer drug. The study’s design had been questioned by scientists.

The news “should have caused NWBO’s share price to increase, absent manipulation in the market”, they wrote, referring to the company’s stock symbol. Instead it dropped from $1.73 to a low of $0.3862.

“This staggering decline of 78 per cent in the price on a day with extremely positive news about the company was caused by defendants’ relentless and brazen manipulation of the market for NWBO shares,” lawyers at Cohen Milstein Sellers & Toll added.

However, the presentation of the DCVax clinical data was not well received by all commentators. “Overall, patients treated with DCVax had a 10 per cent higher risk of tumor progression compared to placebo — an outcome that is the antithesis of what’s required from any effective cancer treatment,” industry specialist publication STAT wrote at the time.

In March, the company had warned in regulatory submissions that “because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the company’s ability to continue as a going concern within one year from the date of this filing”.

Maryland-based Northwest Biotherapeutics has a market capitalisation of about $860mn and is traded on the US over-the-counter market. Its shares currently change hands at about $0.83.

In 2019 the company settled an action by the Securities and Exchange Commission after the regulator found it failed to maintain internal controls over its financial reporting for 12 years.

Aside from Citadel Securities, Susquehanna and Virtu, the lawsuit named Canaccord Genuity, GTS, Instinet, Lime Trading and Susquehanna subsidiary G1 as defendants.

In its complaint, Northwest said it sold 49mn of its shares at artificially deflated prices. It added that there was “an extremely low statistical likelihood” that the price variations in each of the alleged spoofing incidents had occurred due to normal market moves.

Share on TwitterTweet
Share on Pinterest Share
Share on LinkedIn Share
Share on Digg Share
Tags: CryptoStockstock spoofing
Institutional Trading Concept Institutional Trading Concept Institutional Trading Concept
ADVERTISEMENT
Previous Post

Apple Blocks App Update Over NFTs

Next Post

Binance Expands Into New Market Despite Crypto Market Meltdown

Admin

Admin

Next Post
Bitcoin Price Touched $138K On Binance US

Binance Expands Into New Market Despite Crypto Market Meltdown

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

  • 99 Subscribers
  • Trending
  • Comments
  • Latest
yen and dollar

FOREX-Yen Flirts With Intervention Level As Dollar See Gains

October 11, 2022
AUD USD pair

Forex: AUD/USD Point To More Downside For The Aussie

October 20, 2022
Mayowa Owolabi on battles traders need to fight

Battle Every Trader Must Fight (Part 1)- Mayowa Owolabi

August 31, 2022
Axie Infinity price

Axie Infinity Price Eyes 25% Gains Ahead of the Token Unlock

April 21, 2023
XAGUSD pair

XAG/USD Climbs to Mid-$19.00s

4
Premier League Considering Partnership With NFT Crypto Platform

Premier League considering partnership with NFT crypto platform

2
EUR/USD pair

EUR/USD Recovers from 20-year Lows

2
Binance Refocuses Efforts For Belgian Clients

Binance Proof-Of-Reserve Pledge Earns Support Following FTX Crisis

2
Chainalysis Lays Off 15% Of Staff To Curb Expenses

Chainalysis Lays Off 15% Of Staff To Curb Expenses

October 4, 2023
CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

October 3, 2023
Bitcoin Fails To Hold $28,000 Amid Bond Yields Surge, Fed Hike Coming?

Bitcoin Fails To Hold $28,000 Amid Bond Yields Surge, Fed Hike Coming?

October 3, 2023
FOREX: EUR/USD Holds Steady Below 1.0500

FOREX: EUR/USD Holds Steady Below 1.0500

October 3, 2023

Recent News

Chainalysis Lays Off 15% Of Staff To Curb Expenses

Chainalysis Lays Off 15% Of Staff To Curb Expenses

October 4, 2023
CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

October 3, 2023
Bitcoin Fails To Hold $28,000 Amid Bond Yields Surge, Fed Hike Coming?

Bitcoin Fails To Hold $28,000 Amid Bond Yields Surge, Fed Hike Coming?

October 3, 2023
FOREX: EUR/USD Holds Steady Below 1.0500

FOREX: EUR/USD Holds Steady Below 1.0500

October 3, 2023
Financial Market Examiner

Get all the latest Financial Market (Crypto & Forex) news, updates and other relevant resources here.

Follow Us

Browse by Category

  • Crypto News
  • Education
  • Entertainment
  • Forex News
  • Gaming
  • Review
  • Reviews
  • Stocks
  • Uncategorized

Recent News

Chainalysis Lays Off 15% Of Staff To Curb Expenses

Chainalysis Lays Off 15% Of Staff To Curb Expenses

October 4, 2023
CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

CFTC Chair Pushes For DeFi Regulation Amid Industry Tensions

October 3, 2023

© 2022 Financial Market Examiner. - Designed by Mayconcept Solutions.

No Result
View All Result
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews

© 2022 Financial Market Examiner. - Designed by Mayconcept Solutions.

?>